お知らせ • Jan 23
Doseology Sciences Inc. Begins Pilot Production of Caffeine-Based Energy Pouches
Doseology Sciences Inc. announced the initiation of a pilot production run of non-nicotine, caffeine-based energy pouches under its wholly owned Feed That Brain®? brand. Doseology's acquisition of Feed That Brain was a strategic decision rooted in alignment with a consumer demographic the Company views as increasingly influential in shaping the future of the oral stimulant category. The brand was built for modern, performance-minded consumers who value intention, control, and thoughtful design in the products they use - characteristics that align closely with Doseology's vision for next -generation stimulation. Under Doseology's ownership, Feed That Brain now serves as a platform brand within the Company's broader oral stimulant strategy, supporting disciplined evaluation of new delivery formats that emphasize measured, predictable energy rather than excess or intensity. The pilot represents an early step in Doseology's strategy to expand its oral stimulant product portfolio and evaluate pouch-based delivery formats within a controlled, data-driven framework. The products included in the pilot contain no nicotine and are designed to deliver measured caffeine-based energy, with an emphasis on predictability, consistency, and user control. Strategic Pilot for Product and Market Validation. Feed That Brain was originally recognized for its functional gummies and nootropic formulations. Through its integration into Doseology's platform, the brand is now being evaluated as part of a broader initiative to explore non-nicotine oral stimulant formats aligned with evolving consumer preferences. The pilot program is intended to support product testing, consumer feedback, and operational learning. The focus is on controlled delivery - emphasizing consistency and predictability in how energy is accessed, rather than intensity or rapid stimulation. Insights from the pilot are expected to inform future formulation, delivery design, and commercialization decisions. Delivery Format Considerations. Unlike traditional energy beverages, pouch-based formats offer a non-liquid, portion-based, unitized approach to caffeine delivery that does not rely on sugar, carbonation, or large-volume consumption. Pouches are designed for controlled, unitized use, allowing consumers to better manage timing and intake in a discreet and portable format. Doseology's pilot is intended to evaluate how these delivery characteristics influence user experience and behavior in a caffeine-based oral format, rather than to compare performance outcomes versus other energy products. Positioning Within a Global Energy-Focused Category. The global market for energy-focused consumer products continues to expand across multiple formats. According to Grand View Research, the global energy drinks market - a leading segment within the broader energy category - was estimated at approximately $79.4 billion in 2024 and is projected to exceed $125 billion by 2030, reflecting sustained consumer demand for energy-oriented products. At the same time, consumer and regulatory scrutiny around sugar content, portion size, and excess consumption has contributed to growing interest in alternative formats for caffeine intake. As energy drinks face scrutiny for sugar and excess, smaller companies are increasingly testing alternative ways people consume caffeine - with an emphasis on control rather than intensity. Against this backdrop, Doseology's pilot reflects an effort to evaluate how pouch-based delivery formats - independent of nicotine - may be applied to caffeine-based energy use cases, emphasizing control, consistency, and user choice in how energy is accessed. The pilot is exploratory in nature and does not represent a commercial launch. The pilot is exploratory In nature and does not represent a Commercial launch. The Feed That Brain pilot run is expected to be introduced through a limited direct-to-consumer initiative within the coming weeks, with timing to be announced by management. The pilot is designed to generate real-world insights and operational feedback, supporting Doseology's broader objectives to refine delivery formats, strengthen commercialization capabilities, and evaluate scalable pathways for future product development.